Search results
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 22 hours agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 7 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
AbbVie Stock Poised for New All-Time Highs in 2024 | Investing.com
Investing.com· 11 hours agoAbbVie had a better-than-expected quarter and guided higher; the post-release price drop is a dip...
3 Reasons to Buy AbbVie Stock on the Dip
Motley Fool via Yahoo Finance· 3 days agoMany of these medicines are helping smooth out Humira-related losses. The ones doing the bulk of that job, though, are Skyrizi and Rinvoq, a pair of...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 days agoThe acquisition of ImmunoGen has bolstered its oncology pipeline with promising antibody-drug conjugates, enhancing its competitive edge. AbbVie's...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks· 5 days agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days agoAbbVie beat estimates for both earnings and sales in the first quarter. While sales rose 0.7% year...
